Literature DB >> 16854068

Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.

Aranapakam M Venkatesan1, Atul Agarwal, Takao Abe, Hideki Ushirogochi, Itsuka Yamamura, Mihira Ado, Takasaki Tsuyoshi, Osvaldo Dos Santos, Yansong Gu, Fuk-Wah Sum, Zhong Li, Gerry Francisco, Yang-I Lin, Peter J Petersen, Youjun Yang, Toshio Kumagai, William J Weiss, David M Shlaes, James R Knox, Tarek S Mansour.   

Abstract

The design and synthesis of a series of 6-methylidene penems containing [6,5]-fused bicycles (thiophene, imidazole, or pyrazle-fused system) as novel class A, B, and C beta-lactamase inhibitors is described. These penems proved to be potent inhibitors of the TEM-1 (class A) and AmpC (class C) beta-lactamases and less so against the class B metallo-beta-lactamase CcrA. Their in vitro and in vivo activities in combination with piperacillin are discussed. On the basis of the crystallographic structures of a serine-bound reaction intermediate of 2 with SHV-1 (class A) and GC1 (class C) enzymes, compounds 14a-l were designed and synthesized. Penems are proposed to form a seven-membered 1,4 thiazepine ring in both class A and C beta-lactamases. The interaction energy calculation for the enzyme-bound intermediates favor the formation of the C7 R enantiomer over the S enantiomer of the 1,4-thiazepine in both beta-lactamases, which is consistent with those obtained from the crystal structure of 2 with SHV-1 and GC1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854068     DOI: 10.1021/jm060021p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

2.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

3.  Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.

Authors:  Mei Li; Benjamin C Conklin; Magdalena A Taracila; Rebecca A Hutton; Marion J Skalweit
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

4.  The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV beta-lactamase: a study of ambler position Asn276.

Authors:  Sarah M Drawz; Christopher R Bethel; Kristine M Hujer; Kelly N Hurless; Anne M Distler; Emilia Caselli; Fabio Prati; Robert A Bonomo
Journal:  Biochemistry       Date:  2009-06-02       Impact factor: 3.162

5.  Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids.

Authors:  Po C Chen; Rebekah E Wharton; Pratiq A Patel; Adegboyega K Oyelere
Journal:  Bioorg Med Chem       Date:  2007-08-25       Impact factor: 3.641

Review 6.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Kinetic and Structural Characterization of the Interaction of 6-Methylidene Penem 2 with the β-Lactamase from Mycobacterium tuberculosis.

Authors:  Saugata Hazra; Sebastian G Kurz; Kerstin Wolff; Liem Nguyen; Robert A Bonomo; John S Blanchard
Journal:  Biochemistry       Date:  2015-08-31       Impact factor: 3.162

8.  Inhibition of OXA-1 beta-lactamase by penems.

Authors:  Christopher R Bethel; Anne M Distler; Mark W Ruszczycky; Marianne P Carey; Paul R Carey; Andrea M Hujer; Magda Taracila; Marion S Helfand; Jodi M Thomson; Matthew Kalp; Vernon E Anderson; David A Leonard; Kristine M Hujer; Takao Abe; Aranapakam M Venkatesan; Tarek S Mansour; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2008-06-16       Impact factor: 5.191

Review 9.  [3 + 2]-Cycloaddition reaction of sydnones with alkynes.

Authors:  Veronika Hladíková; Jiří Váňa; Jiří Hanusek
Journal:  Beilstein J Org Chem       Date:  2018-06-05       Impact factor: 2.883

Review 10.  New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams.

Authors:  Juan C Vázquez-Ucha; Jorge Arca-Suárez; Germán Bou; Alejandro Beceiro
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.